HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rifaximin therapy in minimal hepatic encephalopathy cirrhotics.

AuthorsAngelo Zullo, Cesare Hassan, Roberto Lorenzetti
JournalThe American journal of gastroenterology (Am J Gastroenterol) Vol. 106 Issue 11 Pg. 2041; author reply 2041-2 (Nov 2011) ISSN: 1572-0241 [Electronic] United States
PMID22056578 (Publication Type: Letter, Comment)
Chemical References
  • Gastrointestinal Agents
  • Rifamycins
Topics
  • Female
  • Gastrointestinal Agents (therapeutic use)
  • Hepatic Encephalopathy (drug therapy)
  • Humans
  • Liver Cirrhosis (drug therapy)
  • Male
  • Quality of Life
  • Rifamycins (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: